The FY2025 (Dec) proxy of SELLAS Life Sciences Group names 17 peer companies for pay. Among SELLAS Life Sciences Group and these peers, CEO pay was the lowest of 4 and total shareholder return was the lowest of 4.
4th highest of 4in SELLAS Life Sciences Group and its pay peers, FY2025 (Dec) by CEO pay:
$1.9M$7.0M
4th highest of 4in SELLAS Life Sciences Group and its pay peers, FY2025 (Dec) by total shareholder return:
$160$906
Pay peer group, FY2025 (Dec) proxy
| Corvus Pharmaceuticals | ||
| Compass Therapeutics | ||
| Verastem | ||
| Actinium Pharmaceuticals, Inc. | Not disclosed | Not disclosed |
| BeyondSpring Inc. | Not disclosed | Not disclosed |
| Cardiff Oncology | Not disclosed | Not disclosed |
| Cellectar Biosciences, Inc. | Not disclosed | Not disclosed |
| Checkpoint Therapeutics, Inc. | Not disclosed | Not disclosed |
| Cidara Therapeutics, Inc. | Not disclosed | Not disclosed |
| Cue Biopharma, Inc. | Not disclosed | Not disclosed |
| Elevation Oncology, Inc. | Not disclosed | Not disclosed |
| Equillium, Inc. | Not disclosed | Not disclosed |
| Genelux Corporation | Not disclosed | Not disclosed |
| Immunic, Inc. | Not disclosed | Not disclosed |
| Leap Therapeutics, Inc. | Not disclosed | Not disclosed |
| PDS Biotechnology Corporation | Not disclosed | Not disclosed |
| Syros Pharmaceuticals | Not disclosed | Not disclosed |
17 companies
Changes by year
No proxy on file names a change to the peer group.
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.